Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
"Blockbuster Status": 3 Bios to Buy and Hold
03:47pm, Wednesday, 13'th Sep 2023
The biotech sector is notorious for its sky-high R&D costs, regulatory hurdles, and lengthy timelines to bring a drug to market. Stock Strategist Andrew Rocco unveils 3 biotech stocks that have broken
Novo Nordisk shares slip on two-for-one stock split
12:52pm, Wednesday, 13'th Sep 2023
Novo Nordisk (NYSE:NVO) shares moved lower after the Denmark-based healthcare company announced its board of directors has approved a two-for-one stock split of its B shares listed on the Nasdaq Copen
Wall Street Lunch: August CPI Won't Phase The Fed
12:01pm, Wednesday, 13'th Sep 2023
August consumer price index aligns with forecasts, Core CPI rose +0.3%. American Airlines lowers Q3 guidance; S&P cuts rating on Advance Auto Parts.
Why Is Novo Nordisk (NVO) Stock Up 95% Today?
07:49am, Wednesday, 13'th Sep 2023
Novo Nordisk (NYSE: NVO ) stock is on the rise Wednesday after the pharmaceutical company announced a split of its shares. According to a press release from Novo Nordisk, shares of NVO stock are unde
US FDA uncertain about supply timeline of Novo Nordisk's weight loss drug
11:48am, Tuesday, 12'th Sep 2023
U.S. Food and Drug Administration on Tuesday changed its estimate for the availability of lower doses of Novo Nordisk's weight-loss drug Wegovy to "to be decided" from its earlier expectation of Septe
Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold
09:59pm, Monday, 11'th Sep 2023
Weight-loss drugs are taking the U.S. by storm. JPMorgan Chase (NYSE: JPM ) is forecasting that the market for weight-loss medications could reach $100 billion in annual sales.
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
09:00am, Sunday, 10'th Sep 2023
Scientists hope that a new class of treatments for alcohol use disorder, smoking and other addictive behaviors is on the horizon.
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
09:19am, Saturday, 09'th Sep 2023
As Novo Nordisk and Eli Lilly duke it out in the weight-loss drug market with Ozempic, Wegovy and Mounjaro, drug company competitors plan to join the fray.
3 Top Healthcare Stocks to Buy for September
09:15am, Saturday, 09'th Sep 2023
UnitedHealth Group is a foundational piece of the healthcare system in America. Demand for Pfizer's Covid vaccine may have waned, but profits are going to good use.
The rise in obesity is having a massive impact on the global economy, according to Goldman Sachs. The bank estimates that obesity will drag down the world's GDP by $4 trillion in 2035.
1 Stock Split Stock to Buy Hand Over Fist Right Now
09:45am, Friday, 08'th Sep 2023
Novo Nordisk is seeing unprecedented growth as demand surges for its diabetes and weight-loss treatments. Following its Q2 earnings release, the company announced a 2-for-1 stock split, which is set t
Mizuho's Jared Holz reacts to JPMorgan's huge obesity drug call
06:58pm, Thursday, 07'th Sep 2023
Jared Holz, Mizuho, joins 'Fast Money' to talk JPMorgans $100 billion call on weight loss drugs.
The 3 Best Stocks to Buy Now: September 2023
06:49pm, Thursday, 07'th Sep 2023
With the United States economy demonstrating strong performance recently, Federal Reserve officials are considering to double their 2023 growth projections. Economic data has consistently exceeded ana
Why Novo Nordisk Stock Topped the Market on Thursday
06:03pm, Thursday, 07'th Sep 2023
The JPMorgan Chase analyst team tracking the European pharmaceutical company boosted its price target. "Boosted" might be an understatement, as the figure was raised by 25%.
Weight-Loss Drug Market Can Hit $100 Billion, J.P. Morgan Says.
11:39am, Thursday, 07'th Sep 2023
Eli Lilly and Denmark's Novo Nordisk are expected to roughly split the market for weight-loss drugs, both as diabetes and obesity treatments.
